These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2805279)

  • 1. Recurrent ischemic events after successful thrombolysis in acute myocardial infarction. The Achilles' heel of thrombolytic therapy.
    White CW
    Circulation; 1989 Nov; 80(5):1482-5. PubMed ID: 2805279
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment strategies after successful thrombolysis in acute myocardial infarction.
    Ramsden CS
    Heart Lung; 1988 Nov; 17(6 Pt 2):777-82. PubMed ID: 2973449
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombotic agents in coronary artery disease.
    Cairns JA; Hirsh J; Lewis HD; Resnekov L; Théroux P
    Chest; 1992 Oct; 102(4 Suppl):456S-481S. PubMed ID: 1395829
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute myocardial infarction: thrombolysis].
    Branzi A; Ortolani P
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):711-5. PubMed ID: 12497809
    [No Abstract]   [Full Text] [Related]  

  • 6. Facilitation of thrombolysis in acute myocardial infarction.
    Gambhir DS
    Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of trimetazidine in the combined therapy of myocardial infarction with left ventricular dysfunction].
    Tereshchenko SN; Aleksandriia LG; Moiseev VS
    Kardiologiia; 2002; 42(10):19-21. PubMed ID: 12494051
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombotics and antiplatelets in acute myocardial infarction.
    Wander GS; Gupta NK
    Indian Heart J; 2011; 63(1):58-65. PubMed ID: 23189866
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.
    Brouwer MA; van den Bergh PJ; Aengevaeren WR; Veen G; Luijten HE; Hertzberger DP; van Boven AJ; Vromans RP; Uijen GJ; Verheugt FW
    Circulation; 2002 Aug; 106(6):659-65. PubMed ID: 12163424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombolytic, antiplatelet, and antithrombotic agents.
    Grines CL
    Am J Cardiol; 1992 Dec; 70(21):18I-26I. PubMed ID: 1471601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocyte aggregation inhibitors, anticoagulants and thrombolytic agents in heart diseases].
    Darius H; Erbel R; Belz GG; Meyer J
    Internist (Berl); 1992 Oct; 33(10):670-83. PubMed ID: 1428685
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombotic and thrombolytic therapy in acute cardiac care.
    Sundrani R; Klein LW
    Crit Care Clin; 2001 Apr; 17(2):379-90, vii. PubMed ID: 11450322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute myocardial infarction: what is new?].
    Boulé S; Gongora A; Randriamora M; Adala D; Courteaux C; Taghipour K; Rifaï A; Bearez E; Hannebicque G
    Ann Cardiol Angeiol (Paris); 2005 Nov; 54(6):344-52. PubMed ID: 17183831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 17. Do interventions provide additional benefit to drug treatment of acute coronary syndromes? A call for a reserved, watchful approach.
    Gulba DC
    Thromb Haemost; 1999 Aug; 82(2):953-61. PubMed ID: 10605809
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvants to thrombolysis after acute myocardial infarction. Does adding antiplatelet agents, antithrombotics, or angioplasty make a difference?
    Figueredo VM; Amidon TM; Wolfe CL
    Postgrad Med; 1994 Dec; 96(8):45-51, 54. PubMed ID: 7991477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 20. [First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors].
    Ferreira R
    Rev Port Cardiol; 1992 Mar; 11(3):261-4. PubMed ID: 1610612
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.